Is Journey Medical Corporation (DERM) a Buy, Sell, or Hold?
Journey Medical Corporation
NASDAQ:DERM
$7.27 USD
$0.15 (2.11%)
- Volume
- 147.3K
- Average Volume
- 273.58K
- Market Capitalization
- $200.08M
- P/E Ratio
- -19.34
- Dividend Yield
- 0.00%
- Price Target
- $11.75
- Year High
- $9.56
- Year Low
- $4.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.72
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
31
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
5
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.27M
DERM Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
DERM Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Toledano Miranda Jayne | director | 2026-07-01 | A-Award | 0 | 2026-07-02 |
| Smith Justin Adam | director | 2026-07-01 | A-Award | 0 | 2026-07-02 |
| Herskowitz Neil | director | 2026-07-01 | A-Award | 0 | 2026-07-02 |
| Toledano Miranda Jayne | director | 2026-06-25 | A-Award | 0 | 2026-06-29 |
| Smith Justin Adam | director | 2026-06-25 | A-Award | 0 | 2026-06-26 |
| Herskowitz Neil | director | 2026-06-25 | A-Award | 0 | 2026-06-26 |
| Pearce Michael Cooper | director | 2026-06-25 | A-Award | 0 | 2026-06-26 |
| ROSENWALD LINDSAY A MD | director | 2026-06-25 | A-Award | 0 | 2026-06-26 |
| Alloush Ramsey | officer: Chief Operating Officer | 2026-04-22 | A-Award | 0 | 2026-04-24 |
| Alloush Ramsey | officer: Chief Operating Officer | 2026-04-22 | A-Award | 5.04 | 2026-04-24 |
| Benesch Joseph | officer: CFO | 2026-04-22 | A-Award | 0 | 2026-04-24 |
| Benesch Joseph | officer: CFO | 2026-04-22 | A-Award | 5.04 | 2026-04-24 |
| Maraoui Claude | director, officer: President & CEO | 2026-04-22 | A-Award | 0 | 2026-04-24 |
| Maraoui Claude | director, officer: President & CEO | 2026-04-22 | A-Award | 5.04 | 2026-04-24 |
| Maraoui Claude | director, officer: President & CEO | 2025-08-25 | M-Exempt | 0.065 | 2025-08-26 |
| Maraoui Claude | director, officer: President & CEO | 2025-08-25 | F-InKind | 7.47 | 2025-08-26 |
| Maraoui Claude | director, officer: President & CEO | 2025-08-25 | M-Exempt | 0.065 | 2025-08-26 |
| ROSENWALD LINDSAY A MD | director | 2025-08-05 | A-Award | 0 | 2025-08-07 |
| Smith Justin Adam | director | 2025-08-05 | A-Award | 0 | 2025-08-07 |
| Toledano Miranda Jayne | director | 2025-08-05 | A-Award | 0 | 2025-08-07 |
| Pearce Michael Cooper | director | 2025-08-05 | A-Award | 0 | 2025-08-07 |
| Herskowitz Neil | director | 2025-08-05 | A-Award | 0 | 2025-08-07 |
| Toledano Miranda Jayne | director | 2025-06-25 | A-Award | 0 | 2025-07-07 |
| ROSENWALD LINDSAY A MD | director | 2025-06-25 | A-Award | 0 | 2025-07-07 |
| Pearce Michael Cooper | director | 2025-06-25 | A-Award | 0 | 2025-07-07 |
| Smith Justin Adam | director | 2025-06-25 | A-Award | 0 | 2025-07-07 |
| Herskowitz Neil | director | 2025-06-25 | A-Award | 0 | 2025-07-07 |
| Alloush Ramsey | officer: Chief Operating Officer | 2025-06-17 | A-Award | 0 | 2025-06-20 |
| Alloush Ramsey | officer: Chief Operating Officer | 2025-06-17 | A-Award | 6.31 | 2025-06-20 |
| Benesch Joseph | officer: CFO | 2025-06-17 | A-Award | 0 | 2025-06-20 |
| Benesch Joseph | officer: CFO | 2025-06-17 | A-Award | 6.31 | 2025-06-20 |
| Maraoui Claude | director, officer: President & CEO | 2025-06-17 | A-Award | 0 | 2025-06-20 |
| Maraoui Claude | director, officer: President & CEO | 2025-06-17 | A-Award | 6.31 | 2025-06-20 |
| Maraoui Claude | director, officer: President & CEO | 2025-05-02 | S-Sale | 6.84 | 2025-05-05 |
| Benesch Joseph | officer: CFO | 2025-05-02 | S-Sale | 6.84 | 2025-05-05 |
| Alloush Ramsey | officer: COO | 2025-05-02 | S-Sale | 6.84 | 2025-05-05 |
| Maraoui Claude | director, officer: President & CEO | 2024-05-01 | A-Award | 0 | 2025-04-16 |
| Maraoui Claude | director, officer: President & CEO | 2024-01-03 | A-Award | 0 | 2025-04-16 |
| Benesch Joseph | officer: CFO | 2024-05-01 | A-Award | 0 | 2025-04-16 |
| Benesch Joseph | officer: CFO | 2024-01-03 | A-Award | 0 | 2025-04-16 |
| Alloush Ramsey | officer: Chief Operating Officer | 2025-04-01 | 0 | 2025-04-04 | |
| Maraoui Claude | director, officer: President & CEO | 2025-03-11 | S-Sale | 5.01 | 2025-03-11 |
| Maraoui Claude | director, officer: President & CEO | 2025-03-06 | S-Sale | 5.04 | 2025-03-10 |
| Maraoui Claude | director, officer: President & CEO | 2025-03-07 | S-Sale | 5.01 | 2025-03-10 |
| Maraoui Claude | director, officer: President & CEO | 2025-03-03 | S-Sale | 5.19 | 2025-03-05 |
| Maraoui Claude | director, officer: President & CEO | 2025-03-04 | S-Sale | 5.04 | 2025-03-05 |
| Maraoui Claude | director, officer: President & CEO | 2025-03-05 | S-Sale | 5.13 | 2025-03-05 |
| Benesch Joseph | officer: CFO | 2025-02-21 | S-Sale | 5.19 | 2025-02-24 |
| Benesch Joseph | officer: CFO | 2024-08-01 | S-Sale | 5.47 | 2024-08-01 |
| Pearce Michael Cooper | director | 2024-07-19 | A-Award | 0 | 2024-07-23 |
| Benesch Joseph | officer: CFO | 2024-07-23 | S-Sale | 5.4 | 2024-07-23 |
| Pearce Michael Cooper | director: | 2024-07-09 | 0 | 2024-07-19 | |
| Smith Justin Adam | director | 2024-07-08 | A-Award | 0 | 2024-07-10 |
| Herskowitz Neil | director | 2024-07-08 | A-Award | 0 | 2024-07-10 |
| Toledano Miranda Jayne | director | 2024-07-08 | A-Award | 0 | 2024-07-10 |
| ROSENWALD LINDSAY A MD | director | 2024-07-08 | A-Award | 0 | 2024-07-10 |
| Fortress Biotech, Inc. | 10 percent owner | 2022-05-12 | J-Other | 0 | 2024-05-31 |
| Fortress Biotech, Inc. | 10 percent owner | 2022-08-12 | J-Other | 0 | 2024-05-31 |
| Fortress Biotech, Inc. | 10 percent owner | 2022-11-12 | J-Other | 0 | 2024-05-31 |
| Fortress Biotech, Inc. | 10 percent owner | 2023-02-12 | J-Other | 0 | 2024-05-31 |
| Fortress Biotech, Inc. | 10 percent owner | 2023-05-12 | J-Other | 0 | 2024-05-31 |
| Fortress Biotech, Inc. | 10 percent owner | 2021-11-16 | 0 | 2024-05-31 | |
| Fortress Biotech, Inc. | 10 percent owner | 2021-11-16 | 0 | 2024-05-31 | |
| ROSENWALD LINDSAY A MD | director | 2024-03-25 | P-Purchase | 3.04 | 2024-03-27 |
| Maraoui Claude | director, officer: President & CEO | 2024-03-22 | P-Purchase | 3.479 | 2024-03-25 |
| Smith Justin Adam | director | 2024-03-22 | P-Purchase | 3.47 | 2024-03-25 |
| ROSENWALD LINDSAY A MD | director | 2024-03-22 | P-Purchase | 3.4 | 2024-03-25 |
| Benesch Joseph | officer: Interim CFO | 2024-02-22 | S-Sale | 3.75 | 2024-02-23 |
| Paley Jeffrey | director | 2023-11-07 | S-Sale | 3.48 | 2023-12-08 |
| Paley Jeffrey | director | 2023-11-08 | S-Sale | 3.76 | 2023-12-08 |
| Paley Jeffrey | director | 2023-11-28 | S-Sale | 5.22 | 2023-11-29 |
| Smith Justin Adam | director | 2023-10-13 | P-Purchase | 2.98 | 2023-10-17 |
| Paley Jeffrey | director | 2023-10-06 | P-Purchase | 2.98 | 2023-10-10 |
| Paley Jeffrey | director | 2023-09-21 | P-Purchase | 2.97 | 2023-09-25 |
| Maraoui Claude | director, officer: President & CEO | 2023-09-06 | P-Purchase | 2.52 | 2023-09-08 |
| ROSENWALD LINDSAY A MD | director | 2023-09-06 | P-Purchase | 2.23 | 2023-09-08 |
| Herskowitz Neil | director | 2023-07-21 | A-Award | 0 | 2023-07-25 |
| Paley Jeffrey | director | 2023-07-21 | A-Award | 0 | 2023-07-25 |
| Smith Justin Adam | director | 2023-07-21 | A-Award | 0 | 2023-07-25 |
| Toledano Miranda Jayne | director | 2023-07-21 | A-Award | 0 | 2023-07-25 |
| Maraoui Claude | director, officer: President & CEO | 2023-07-24 | S-Sale | 1.76 | 2023-07-25 |
| Benesch Joseph | officer: See Remarks | 2023-07-24 | S-Sale | 1.76 | 2023-07-25 |
| Maraoui Claude | director, officer: President & CEO | 2023-05-16 | S-Sale | 1.25 | 2023-05-18 |
| Maraoui Claude | director, officer: President & CEO | 2023-05-17 | S-Sale | 1.34 | 2023-05-18 |
| De Paolantonio Ernest Robert | officer: See Remarks | 2022-10-04 | S-Sale | 2.41 | 2023-03-01 |
| Benesch Joseph | officer: Interim CFO | 2023-02-22 | S-Sale | 1.97 | 2023-02-23 |
| Benesch Joseph | officer: Interim CFO | 2023-01-27 | 0 | 2023-01-31 | |
| De Paolantonio Ernest Robert | officer: Chief Financial Officer | 2022-10-04 | S-Sale | 2.41 | 2022-10-06 |
| ROSENWALD LINDSAY A MD | director: | 2022-07-21 | A-Award | 0 | 2022-07-25 |
| Smith Justin Adam | director: | 2022-07-21 | A-Award | 0 | 2022-07-25 |
| Paley Jeffrey | director: | 2022-07-21 | A-Award | 0 | 2022-07-25 |
| Herskowitz Neil | director: | 2022-07-21 | A-Award | 0 | 2022-07-25 |
| Toledano Miranda Jayne | director: | 2022-07-21 | A-Award | 0 | 2022-07-25 |
| Maraoui Claude | officer: President & CEO | 2022-07-21 | A-Award | 0 | 2022-07-25 |
| De Paolantonio Ernest Robert | officer: Chief Financial Officer | 2022-07-21 | A-Award | 0 | 2022-07-25 |
| ROSENWALD LINDSAY A MD | director | 2021-11-26 | 0 | 2022-07-25 | |
| ROSENWALD LINDSAY A MD | director | 2017-12-15 | 0.596 | 2022-07-25 | |
| Herskowitz Neil | director | 2022-01-14 | A-Award | 0 | 2022-04-04 |
| Toledano Miranda Jayne | director | 2022-01-14 | A-Award | 0 | 2022-04-04 |
| Paley Jeffrey | director | 2022-01-14 | A-Award | 0 | 2022-04-04 |